Innovations in Digital Health, Biomanufacturing, Biopharmaceuticals, Genomics, and Diagnostics, 2019 Study - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jun 7, 2019--
The “Innovations in Digital Health, Biomanufacturing, Biopharmaceuticals, Genomics, and Diagnostics” report has been added to ResearchAndMarkets.com’s offering.
The Life Science, Health & Wellness TechVision Opportunity Engine (TOE) covers innovations and new developments across global digital health, biomanufacturing, pharmaceutical, biological, genomic and diagnostic landscapes. This TOE also analyzes research advances across immune-oncology and depression.
The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery, and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
- Akili Interactive Labs
- Codiak Biosciences
- Molecular Templates
- 4D Molecular Therapeutics
- Sherlock Biosciences
- Ares Genetics
- T2 Biosystems
- 1DROP Diagnostics
- Karius Inc.
- DAYZERO Diagnostics
- Sight Diagnostics
- Immunetics Inc.
- ERADA Technology Alliance Limited
- Paragon Bioservices
- Chr Hansen
- Royal College of Surgeons
- MedGenesis Therapeutix
- University of California, San Francisco
- Five Prime Therapeutics
- University of North Carolina
For more information about this report visit https://www.researchandmarkets.com/r/cbi04d
View source version on businesswire.com:https://www.businesswire.com/news/home/20190607005265/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 06/07/2019 09:00 AM/DISC: 06/07/2019 09:01 AM